Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

AIDS (London, England) - 29 Mar 2002

Meynard Jean-Luc, Vray Muriel, Morand-Joubert Laurence, Race Esther, Descamps Diane, Peytavin Gilles, Matheron Sophie, Lamotte Claire, Guiramand Sonia, Costagliola Dominique, Brun-Vézinet Françoise, Clavel François, Girard Pierre-Marie

Abstract excerpt

OBJECTIVE: To assess the respective value of phenotype versus genotype versus standard of care for choosing antiretroviral therapy in patients failing protease inhibitor-containing regimens. METHODS: Patients with plasma HIV-1 RNA exceeding 1000 copies/ml were randomly allocated to phenotyping, genotyping, or standard of care. RESULTS: Five-hundred and forty-one patients were randomized, 190 to phenotyping, 192...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Tolerance

Share to HIV Protease Inhibitors

Share to Patient Compliance

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 11964529
DOI: 10.1097/00002030-200203290-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.PMID 11964529Read ↗

Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.Semantic proximity Read ↗

Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).Semantic proximity Read ↗

Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis.Semantic proximity Read ↗

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).Semantic proximity Read ↗

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Semantic proximity Read ↗

HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?Semantic proximity Read ↗

Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.Semantic proximity Read ↗

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.Semantic proximity Read ↗

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.Semantic proximity Read ↗

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.